Pancreatic Cancer Research

ResearcherUniversity of IowaActive in the last 2 years

Brianne R. O’Leary

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7431-1141; OpenAlex author ID A5055806263. Sources: OpenAlex.

Their work

Papers
14 (first author 6, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 3 papers · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 14

  1. Pharmacologic ascorbate resistant pancreatic cancer demonstrates enhanced metastatic potential. First author DOI 10.1016/j.redox.2025.103694↗
  2. Pharmacologic Ascorbate Radiosensitizes Pancreatic Cancer but Radioprotects Normal Tissue: The Role of Oxidative Stress-Induced Lipid Peroxidation. First author DOI 10.3390/antiox13030361↗
  3. Hydrogen Peroxide Mediates Pharmacological Ascorbate Induced Radio-Sensitization of Pancreatic Cancer Cells by Enhancing G2-accumulation and Reducing Cyclin B1… Co-author DOI 10.1667/rade-22-00182.1↗
  4. Pharmacologic Ascorbate and DNMT Inhibitors Increase DUOX Expression and Peroxide-Mediated Toxicity in Pancreatic Cancer. First author DOI 10.3390/antiox12091683↗
  5. Pharmacological Ascorbate Enhances Chemotherapies in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002086↗
  6. Auranofin and Pharmacologic Ascorbate as Radiomodulators in the Treatment of Pancreatic Cancer. Co-author DOI 10.3390/antiox11050971↗
  7. Catalase Modulates the Radio-Sensitization of Pancreatic Cancer Cells by Pharmacological Ascorbate. Co-author DOI 10.3390/antiox10040614↗
  8. Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism. Co-author DOI 10.1038/s41598-020-74806-2↗
  9. Arachidonate 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid contribute to stromal aging-induced progression of pancreatic cancer. Co-author DOI 10.1074/jbc.ra120.012798↗
  10. Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer. First author DOI 10.1667/rr15189.1↗
  11. Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma. First author DOI 10.1007/s10585-018-9876-z↗
  12. Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-18-1680↗
  13. A model for the detection of pancreatic ductal adenocarcinoma circulating tumor cells. First author DOI 10.14440/jbm.2018.250↗
  14. Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-14-1959↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joseph J. Cullen · 13 shared papers, 2018–2025 · strength 2.04
  2. Juan Du · 11 shared papers, 2018–2024 · strength 1.50
  3. Garry R. Buettner · 9 shared papers, 2015–2025 · strength 1.31
  4. Garett J. Steers · 5 shared papers, 2021–2024 · strength 0.92
  5. Matthew S. Alexander · 6 shared papers, 2018–2020 · strength 0.58
  6. Amanda N. Pope · 2 shared papers, 2023–2025 · strength 0.54
  7. Prabhat C. Goswami · 3 shared papers, 2020–2023 · strength 0.54
  8. Gloria Y. Chen · 2 shared papers, 2022–2024 · strength 0.43
  9. Juan Du · 1 shared paper, 2025 · strength 0.30
  10. Justin G. Wilkes · 3 shared papers, 2018–2019 · strength 0.24
  11. Ehab H. Sarsour · 2 shared papers, 2019–2020 · strength 0.21
  12. Douglas Robert Spitz · 2 shared papers, 2015–2018 · strength 0.11
  13. Bryan G. Allen · 2 shared papers, 2015–2018 · strength 0.11
  14. Rosa F. Hwang · 1 shared paper, 2019 · strength 0.09
  15. Zita A. Sibenaller · 1 shared paper, 2018 · strength 0.08
  16. Susan Tsai · 1 shared paper, 2018 · strength 0.08
  17. Daniel Berg · 1 shared paper, 2018 · strength 0.07
  18. John Michael Buatti · 1 shared paper, 2018 · strength 0.07
  19. Kellie L. Bodeker · 1 shared paper, 2018 · strength 0.07
  20. Wendy Cozen · 1 shared paper, 2015 · strength 0.04
  21. Charles F. Lynch · 1 shared paper, 2015 · strength 0.04
  22. James J. Mezhir · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.